Improving the anti-keloid outcomes through liposomes loading paclitaxel–cholesterol complexes

References

• WulandariEJusmanSWMoenadjatYJusufAASadikinMEndahWExpressions of collagen I and III in hypoxic keloid tissueKobe J Med Sci2016623E58E6927604536
   PubMedGoogle Scholar
• AndrewsJPMarttalaJMacarakERosenbloomJUittoJKeloids: The paradigm of skin fibrosis – pathomechanisms and treatmentMatrix Biol201651374626844756
   PubMed Web of Science ®Google Scholar
• BranGMGoesslerURHormannKRiedelFSadickHKeloids: current concepts of pathogenesis (review)Int J Mol Med20092428329319639219
   PubMed Web of Science ®Google Scholar
• Trisliana PerdanasariALazzeriDSuWRecent developments in the use of intralesional injections keloid treatmentArch Plast Surg20144162062925396172
   PubMedGoogle Scholar
• GauglitzGGKortingHCPavicicTRuzickaTJeschkeMGHypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategiesMol Med2011171–2125
   Google Scholar
• OgawaRKeloid and hypertrophic scars are the result of chronic inflammation in the reticular dermisInt J Mol Sci2017183606
   PubMed Web of Science ®Google Scholar
• JiaoHDongPYanLTGF-β1 induces polypyrimidine tractbinding protein to alter fibroblasts proliferation and fibronectin deposition in keloidSci Rep2016613803327897224
   PubMedGoogle Scholar
• SandulacheVCParekhALi-KorotkyHDoharJEHebdaPAProstaglandin E2 inhibition of keloid fibroblast migration, contraction, and transforming growth factor (TGF)-beta1-induced collagen synthesisWound Repair Regen200715112213317244328
   PubMedGoogle Scholar
• NirodiCSDevalarajaRNanneyLBChemokine and chemokine receptor expression in keloid and normal fibroblastsWound Repair Regen20008537138211115149
   PubMed Web of Science ®Google Scholar
• ZhangQYamazaTKellyAPTumor-like stem cells derived from human keloid are governed by the inflammatory niche driven by IL-17/IL-6 axisPLoS One2009411e779819907660
   PubMed Web of Science ®Google Scholar
• DerynckRZhangYESmad-dependent and Smad-independent pathways in TGF-beta family signallingNature2003425695857758414534577
   PubMed Web of Science ®Google Scholar
• DongXMaoSWenHXianglinDUpregulation of proinflammatory genes in skin lesions may be the cause of keloid formation (review)Biomed Rep20131683383624649037
   PubMedGoogle Scholar
• WangCWangRZhouKJD enhances the anti-tumour effects of low-dose paclitaxel on gastric cancer MKN45 cells both in vitro and in vivoCancer Chemother Pharmacol201678597198227620208
   PubMedGoogle Scholar
• JinMJinGKangLChenLGaoZHuangWSmart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomesInt J Nanomedicine201813132405242629719390
   PubMedGoogle Scholar
• JeongJYKimKSMoonJSTargeted inhibition of phosphatidyl inositol-3-kinase p110β, but not p110α, enhances apoptosis and sensitivity to paclitaxel in chemoresistant ovarian cancersApoptosis201318450952023371322
   PubMedGoogle Scholar
• KampanNCMadondoMTMcNallyOMQuinnMPlebanskiMPaclitaxel and its evolving role in the management of ovarian cancerBioMed Res Int201520151121
   Google Scholar
• Quispe-SotoETCalafGMEffect of curcumin and paclitaxel on breast carcinogenesisInt J Oncol20164962569257727779649
   PubMed Web of Science ®Google Scholar
• ZhangLXuXYangRPaclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting Stat3 signalingDrug Des Devel Ther2015921392148
   PubMed Web of Science ®Google Scholar
• ZhouJPaclitaxel ameliorates fibrosis in hepatic stellate cells via inhibition of TGF-β/Smad activityWorld J Gastroenterol201016263330333420614491
   PubMed Web of Science ®Google Scholar
• TsukadaTFushidaSHaradaSLow-dose paclitaxel modulates tumour fibrosis in gastric cancerInt J Oncol20134241167117423443842
   PubMed Web of Science ®Google Scholar
• ZhangDLiYLiuYXiangXDongZPaclitaxel ameliorates lipopolysaccharide-induced kidney injury by binding myeloid differentiation protein-2 to block Toll-like receptor 4-mediated nuclear factor-κB activation and cytokine productionJ Pharmacol Exp Ther20133451697523318472
   PubMed Web of Science ®Google Scholar
• ColomboADrzewieckiJBanningARandomized study to assess the effectiveness of slow-and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesionsCirculation2003108778879412900339
   PubMed Web of Science ®Google Scholar
• StoneGWEllisSGCoxDAA polymer-based, paclitaxel-eluting stent in patients with coronary artery diseaseN Engl J Med2004350322123114724301
   PubMed Web of Science ®Google Scholar
• ChenLQHuangWGaoZGFangWSJinMJL×2-32c-loaded polymeric micelles with small size for intravenous drug delivery and their inhibitory effect on tumor growth and metastasis in clinically associated 4T1 murine breast cancerInt J Nanomedicine2016115457547227799769
   PubMed Web of Science ®Google Scholar
• HuCChenZWuSMicelle or polymersome formation by PCL-PEG-PCL copolymers as drug delivery systemsChin Chem Lett201728919051909
   Web of Science ®Google Scholar
• LuoZJiangLDingCSurfactant free delivery of docetaxel by poly[(R)-3-hydroxybutyrate-(R)-3-hydroxyhexanoate]-based polymeric micelles for effective melanoma treatmentsAdv Healthc Mater20187231801221
   Google Scholar
• LiuXLiZLohXJChenKLiZWuYLTargeted and sustained co-release of chemotherapeutics and gene by injectable supramolecular hydrogel for drug-resistant cancer therapyMacromol Rapid Commun201810e1800117
   Google Scholar
• ChenXQiuYKOwhCLohXJWuYLSupramolecular cyclodextrin nanocarriers for chemo-and gene therapy towards the effective treatment of drug resistant cancersNanoscale2016845188761888127819368
   PubMedGoogle Scholar
• LiuYMeiLYuQMultifunctional tandem peptide modified paclitaxel-loaded liposomes for the treatment of vasculogenic mimicry and cancer stem cells in malignant gliomaACS Appl Mater Interfaces2015730167921680126173814
   PubMed Web of Science ®Google Scholar
• JainRKStylianopoulosTDelivering nanomedicine to solid tumorsNat Rev Clin Oncol201071165366420838415
   PubMed Web of Science ®Google Scholar
• YingchoncharoenPKalinowskiDSRichardsonDRLipid-based drug delivery systems in cancer therapy: what is available and what is yet to comePharmacol Rev201668370178727363439
   PubMed Web of Science ®Google Scholar
• YeJLiuYXiaXImproved safety and efficacy of a lipid emulsion loaded with a paclitaxel-cholesterol complex for the treatment of breast tumorsOncol Rep201636139940927175803
   PubMed Web of Science ®Google Scholar
• HongSSChoiJYKimJOLeeMKKimSHLimSJDevelopment of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporationInt J Nanomedicine2016114465447727660440
   PubMed Web of Science ®Google Scholar
• RodriguesDGCovolanCCCoradiSTBarbozaRMaranhãoRCUse of a cholesterol-rich emulsion that binds to low-density lipoprotein receptors as a vehicle for paclitaxelJ Pharm Pharmacol200254676577212078992
   PubMed Web of Science ®Google Scholar
• RodriguesDGMariaDAFernandesDCImprovement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion: in vitro and in vivo studiesCancer Chemother Pharmacol200555656557615726368
   PubMed Web of Science ®Google Scholar
• XiaXJGuoRFLiuYLFormulation, characterization and hypersensitivity evaluation of an intravenous emulsion loaded with a paclitaxel-cholesterol complexChem Pharm Bull201159332132621372412
   PubMedGoogle Scholar
• WangXLiZNWangQMJinHYGaoZJinZHLipid nano-bubble combined with ultrasound for anti-keloids therapyJ Liposome Res2016281128
   Google Scholar
• BollrathJPhesseTJvon BurstinVAGp130-mediated STAT3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesisCancer Cell20091529110219185844
   PubMed Web of Science ®Google Scholar
• GrivennikovSKarinETerzicJIL-6 and STAT3 are required for survival of intestinal epithelial cells and development of colitis-associated cancerCancer Cell200915210311319185845
   PubMed Web of Science ®Google Scholar
• MirlashariMRRandenIKjeldsen-KraghJGlycogen synthase kinase-3 (GSK-3) inhibition induces apoptosis in leukemic cells through mitochondria-dependent pathwayLeuk Res201236449950822177455
   PubMedGoogle Scholar
• ManningBDTokerAAkt/PKB signaling: navigating the networkCell2017169338140528431241
   PubMed Web of Science ®Google Scholar
• McQueenJvan DykDYoungBLoewenCMeasdayVThe mck1 GSK-3 kinase inhibits the activity of Clb2-Cdk1 post-nuclear divisionCell Cycle201211183421343222918234
   PubMed Web of Science ®Google Scholar
• McCubreyJASteelmanLSBertrandFEGSK-3 as potential target for therapeutic intervention in cancerOncotarget20145102881291124931005
   PubMedGoogle Scholar
• HongHChenFQiaoYGSK-3β activation index is a potential indicator for recurrent inflammation of chronic rhinosinusitis without nasal polypsJ Cell Mol Med201721123633364028714566
   PubMedGoogle Scholar
• RenXZhaoBChangHXiaoMWuYLiuYPaclitaxel suppresses proliferation and induces apoptosis through regulation of ROS and the AKT/MAPK signaling pathway in canine mammary gland tumor cellsMol Med Rep20181768289829929658576
   PubMedGoogle Scholar